- Cocrystal Pharma Inc Annual Shareholders Meeting TranscriptJun 08, 2023
- Cocrystal Pharma Inc Virtual Investor Summit TranscriptMar 29, 2023
- Cocrystal Pharma Inc at SRAX Sequire Biotechnology Conference (Virtual) TranscriptFeb 02, 2023
- Cocrystal Pharma Inc at Noble Capital Markets and Channelcheck C-Suite Interview Series (Virtual) TranscriptFeb 01, 2023
- Cocrystal Pharma Inc at Noble Capital Markets Takeaway Series on Channelchek- J.P. Morgan Healthcare Conference TranscriptJan 26, 2023
- Cocrystal Pharma Inc Q4 Investor Summit TranscriptNov 14, 2022
- Cocrystal Pharma Inc at LD Micro Main Event TranscriptOct 26, 2022
- Cocrystal Pharma Inc Annual Shareholders Meeting TranscriptMay 18, 2022
- Cocrystal Pharma Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
Cocrystal Pharma Inc Q4 Investor Summit Transcript
(multiple speakers) Good morning, I would like to introduce James Martin, the Co-CFO and CEO (sic - Interim Co-CEO and CFO) of Cocrystal.
Hello everyone. Thank you for attending the investor conference and your interest in Cocrystal Pharma. If you guys are ready, I'll get started here. Cocrystal as a NASDAQ listed company under the ticker symbol COCP. Start off with forward-looking statements. I encourage you to read them and also you can check out our filings on the sec.gov.
So what does Cocrystal do? Cocrystal is an antiviral company. And the space we're in is for therapeutics, primarily in influenza, COVID, norovirus and hepatitis C. We use a highly conserved region of these viruses in which we attach our molecules, and I'll get more into that in a minute. But all of this is driven by a proprietary drug discovery platform.
So investment highlights at Cocrystal are summarized as we target large global markets. These are influenza, COVID. These are both acute and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)